Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
57.05
-0.06 (-0.11%)
Nov 8, 2024, 4:00 PM EST - Market closed

Soleno Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
2,4601,2281633154131
Upgrade
Market Cap Growth
335.62%7498.61%-50.63%-78.71%17.03%142.15%
Upgrade
Enterprise Value
2,1811,176-3598120
Upgrade
Last Close Price
57.1140.251.986.1528.9544.10
Upgrade
PE Ratio
--17.03-0.69-1.06-4.91-3.26
Upgrade
PB Ratio
8.857.791.561.843.378.78
Upgrade
P/FCF Ratio
-38.01-49.22-0.78-1.18-6.09-7.55
Upgrade
P/OCF Ratio
-38.17-49.22-0.78-1.18-6.09-7.56
Upgrade
EV/EBITDA Ratio
-12.22-32.020.15-0.17-3.26-5.65
Upgrade
EV/EBIT Ratio
-12.05-30.400.13-0.16-3.06-5.18
Upgrade
EV/FCF Ratio
-32.31-47.140.16-0.18-3.87-6.90
Upgrade
Debt / Equity Ratio
0.010.000.010.030.000.03
Upgrade
Debt / FCF Ratio
-0.06-0.02-0.01-0.02-0.01-0.03
Upgrade
Quick Ratio
17.1614.752.002.665.714.18
Upgrade
Current Ratio
17.2614.892.142.805.834.26
Upgrade
Return on Equity (ROE)
-91.11%-46.45%-171.05%-97.60%-81.46%-135.69%
Upgrade
Return on Assets (ROA)
-48.05%-23.33%-50.58%-40.11%-38.72%-35.66%
Upgrade
Return on Capital (ROIC)
-59.39%-28.70%-109.16%-63.06%-65.35%-63.27%
Upgrade
Earnings Yield
-5.32%-3.18%-148.97%-94.47%-16.03%-23.44%
Upgrade
FCF Yield
-2.10%-2.03%-128.71%-84.94%-16.42%-13.25%
Upgrade
Buyback Yield / Dilution
-271.22%-96.40%-57.90%-27.39%-83.41%-62.77%
Upgrade
Total Shareholder Return
-271.22%-96.40%-57.90%-27.39%-83.41%-62.77%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.